Zytiga 250 mg Alternative – Zytix (Abiraterone Acetate) 250 mg Tablet | Beacon Pharmaceuticals

Zytix 250 mg (Abiraterone Acetate) Tablet by Beacon Pharmaceuticals. Reference brand: Zytiga. androgen synthesis inhibitor; used in selected advanced prostate cancer with corticosteroid therapy. Prescription medicine. Brand comparison does not establish interchangeability.

Votrient 400 mg Alternative – Zopanib (Pazopanib) 400 mg Tablet | Beacon Pharmaceuticals

Zopanib 400 mg (Pazopanib) Tablet by Beacon Pharmaceuticals. Reference brand: Votrient. multikinase inhibitor; used in selected advanced renal cell carcinoma and soft tissue sarcoma. Prescription medicine. Brand comparison does not establish interchangeability.

Votrient 200 mg Alternative – Zopanib (Pazopanib) 200 mg Tablet | Beacon Pharmaceuticals

Zopanib 200 mg (Pazopanib) Tablet by Beacon Pharmaceuticals. Reference brand: Votrient. multikinase inhibitor; used in selected advanced renal cell carcinoma and soft tissue sarcoma. Prescription medicine. Brand comparison does not establish interchangeability.

Xeloda 500 mg Alternative – Xitabin (Capecitabine) 500 mg Tablet | Beacon Pharmaceuticals

Xitabin 500 mg (Capecitabine) Tablet by Beacon Pharmaceuticals. Reference brand: Xeloda. oral fluoropyrimidine chemotherapy; used in selected colorectal and breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Afinitor 5 mg Alternative – XeviroI (Everolimus) 5 mg Tablet | Beacon Pharmaceuticals

XeviroI 5 mg (Everolimus) Tablet by Beacon Pharmaceuticals. Reference brand: Afinitor. mTOR inhibitor; used in selected breast, kidney and neuroendocrine cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Temodar 250 mg Alternative – Temonix (Temozolomide) 250 mg Capsule | Beacon Pharmaceuticals

Temonix 250 mg (Temozolomide) Capsule by Beacon Pharmaceuticals. Reference brand: Temodar. alkylating chemotherapy; used in selected brain tumors including glioblastoma. Prescription medicine. Brand comparison does not establish interchangeability.

Temodar 100 mg Alternative – Temonix (Temozolomide) 100 mg Capsule | Beacon Pharmaceuticals

Temonix 100 mg (Temozolomide) Capsule by Beacon Pharmaceuticals. Reference brand: Temodar. alkylating chemotherapy; used in selected brain tumors including glioblastoma. Prescription medicine. Brand comparison does not establish interchangeability.

Nolvadex 20 mg Alternative – Tamoxi (Tamoxifen) 20 mg Tablet | Beacon Pharmaceuticals

Tamoxi 20 mg (Tamoxifen) Tablet by Beacon Pharmaceuticals. Reference brand: Nolvadex. selective estrogen receptor modulator; used in selected hormone receptor-positive breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Sutent 50 mg Alternative – Sunitix (Sunitinib) 50 mg Capsule | Beacon Pharmaceuticals

Sunitix 50 mg (Sunitinib) Capsule by Beacon Pharmaceuticals. Reference brand: Sutent. multikinase inhibitor; used in selected kidney cancer, GIST and pancreatic neuroendocrine tumors. Prescription medicine. Brand comparison does not establish interchangeability.

Nexavar 200 mg Alternative – Soranix (Sorafenib) 200 mg Tablet | Beacon Pharmaceuticals

Soranix 200 mg (Sorafenib) Tablet by Beacon Pharmaceuticals. Reference brand: Nexavar. multikinase inhibitor; used in selected liver, kidney and thyroid cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Orgovyx 120 mg Alternative – Relugoli (Relugolix) 120 mg Tablet | Beacon Pharmaceuticals

Relugoli 120 mg (Relugolix) Tablet by Beacon Pharmaceuticals. Reference brand: Orgovyx. GnRH receptor antagonist; used in selected advanced prostate cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Kisqali 200 mg Alternative – Ribolib (Ribociclib) 200 mg Tablet | Beacon Pharmaceuticals

Ribolib 200 mg (Ribociclib) Tablet by Beacon Pharmaceuticals. Reference brand: Kisqali. CDK4/6 inhibitor; used in selected HR-positive, HER2-negative breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.